UC Davis to use precision medicine in pancreatic cancer care

Sacramento-based UC Davis Comprehensive Cancer Center will use next generation sequencing analysis on patients diagnosed with hematological malignancies and pancreatic cancer.

Advertisement

The strategy will be deployed through a partnership with Tempus, a health technology company focused on personalized oncology care. Under the partnership, Tempus will work with a team of investigators led by Primo Lara, MD, interim director of the UC Davis Comprehensive Cancer Center.

Tempus will use machine learning and advanced bioinformatics to support physicians as they analyze patient molecular data. The goal of the partnership is to identify patterns to guide treatment for patients who are unlikely to respond to standard therapies.

More articles on data analytics & precision medicine:
Kalorama: Apple, Google, IBM make waves in healthcare analytics market
Intermountain, U of Utah Health to develop EHR clinical decision support under $3.8M NCI grant
University of Rochester Medical Center taps NextGate to aggregate provider data

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Digital Health

Advertisement

Comments are closed.